CRF and SCAI Present an
In-Depth TAVR Series

TAVR at the Crossroads:

Transitioning to a Mainstream Therapy

Thursday, May 5, 2016

Lunch Program

11:30 am: Check-in & Lunch
12:00 pm-1:00 pm: Program

Hyatt Regency Orlando
Room: Celebration 5/6
9801 INTERNATIONAL DRIVE
ORLANDO, FL 32819

TAVR In the
Real World:

Practice Standards and
New Clinical Indications

Friday, May 6, 2016

Lunch Program

11:30 am: Check-in & Lunch
12:00 pm-1:00 pm: Program

Hyatt Regency Orlando
Room: Orlando Ballroom M
9801 INTERNATIONAL DRIVE
ORLANDO, FL 32819


Overview

The emergence of TAVR has provided an alternative to surgery for many eligible high-risk patients suffering from aortic valve disease. With advancements in device development and novel technologies, the transcatheter approach to aortic valve replacement is poised to grow. The goal of these programs is to provide the audience with a foundation for the current role of TAVR in the treatment of patients with aortic stenosis in order to improve the knowledge and competence of attendees, thereby improving patient care and outcomes. The faculty will explore the criteria used in the treatment decision of TAVR versus surgical valve replacement is made, and clinical trial data will be analyzed and discussed to determine the potential expansion of TAVR as the standard of care for low- and intermediate-risk patients. Based on current evidence, the program will also address how TAVR outcomes can be improved and how TAVR centers can prepare for the potential expansion of TAVR into broader patient indications.

REGISTER

There is no cost to register. You must be a SCAI 2016 registrant to attend these satellite programs.

Should you have any questions, please contact Catherine Brosnan at cbrosnan@crf.org.

Register Now